This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Coca-Cola Beats Q3 Earnings & Sales Estimates, Revises 2024 View
by Zacks Equity Research
KO's Q3 results reflect gains from higher pricing across inflationary markets, offset by lower concentrate sales and adverse currency rates.
Vital Farms (VITL) Rises Yet Lags Behind Market: Some Facts Worth Knowing
by Zacks Equity Research
Vital Farms (VITL) closed at $40.35 in the latest trading session, marking a +0.2% move from the prior day.
Vital Farms (VITL) Ascends But Remains Behind Market: Some Facts to Note
by Zacks Equity Research
In the latest trading session, Vital Farms (VITL) closed at $39.95, marking a +0.45% move from the previous day.
Are Consumer Staples Stocks Lagging KimberlyClark (KMB) This Year?
by Zacks Equity Research
Here is how Kimberly-Clark (KMB) and Vital Farms (VITL) have performed compared to their sector so far this year.
Wall Street Bulls Look Optimistic About Vital Farms (VITL): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Vital Farms (VITL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Why Vital Farms (VITL) Dipped More Than Broader Market Today
by Zacks Equity Research
The latest trading day saw Vital Farms (VITL) settling at $35.49, representing a -1.58% change from its previous close.
Morning Omelet? Vital Farms Surges Amid Egg Price Spike
by Bryan Hayes
Egg prices have surged more than 28% in the past year, which bodes well for farmers like Vital Farms.
Vital Farms (VITL) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Vital Farms (VITL) closed at $35.13 in the latest trading session, marking a +0.89% move from the prior day.
Vital Farms (VITL) Flat As Market Sinks: What You Should Know
by Zacks Equity Research
In the closing of the recent trading day, Vital Farms (VITL) stood at $35.73, denoting no change from the preceding trading day.
Is Holding Vital Farms Stock a Wise Call After 40% Gain in Six Months?
by Sumit Singh
Vital Farms' market expansion and decent Q2 2024 results may encourage shareholders to stay on board for continued growth potential.
Vital Farms (VITL) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, Vital Farms (VITL) stood at $31.98, denoting a -1.39% change from the preceding trading day.
Vital Farms (VITL) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
In the most recent trading session, Vital Farms (VITL) closed at $31.42, indicating a +0.22% shift from the previous trading day.
Wall Street Analysts Think Vital Farms (VITL) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Vital Farms (VITL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
How Will the Sale of 51.8% Interest in Agro Tech Foods Aid CAG Stock?
by Zacks Equity Research
Conagra announces the completion of the divestiture of its 51.8% ownership stake in Agro Tech Foods that is set to enhance its portfolio.
The J.M. Smucker Q1 Earnings Top Estimates, SJM Stock Down on View Cut
by Zacks Equity Research
J.M.Smucker's Q1 show reflects sales and earnings growth despite a tough consumer landscape. SJM cuts view due to a dynamic landscape and green coffee costs.
Has The New York Times Company (NYT) Outpaced Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how New York Times Co. (NYT) and Vital Farms (VITL) have performed compared to their sector so far this year.
CENT Stock Declines 11% in 3 Months: Should You Buy, Hold or Sell?
by Zacks Equity Research
Central Garden & Pet Company is facing softness in new pet adoptions as well as lower foot traffic at home center retailers.
Hain Celestial Q4 Earnings Top, Hain Reimagined Strategy Yields
by Zacks Equity Research
HAIN's fourth-quarter fiscal 2024 results show increased earnings on the back of the effectiveness of the Hain Reimagined strategy despite a year-over-year decline in sales.
Vital Farms (VITL) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Vital Farms (VITL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Medifast's (MED) Strategies Aid Amid Evolving Market Demands
by Zacks Equity Research
Medifast (MED) is making efforts to thrive in the rapidly evolving weight loss market, as the adoption of GLP-1 medications reshapes industry dynamics.
BJ's Wholesale (BJ) Stock Falls Despite Q2 Earnings Beat, Comps Growth
by Zacks Equity Research
BJ's Wholesale Club's (BJ) second-quarter earnings results reflect growth in digitally enabled comparable sales. The metric surges 22% during the quarter.
Zacks.com featured highlights Vital Farms, PulteGroup, Hamilton Insurance, Greenbrier and Kratos
by Zacks Equity Research
Vital Farms, PulteGroup, Hamilton Insurance, Greenbrier and Kratos have been highlighted in this Screen of The Week article.
Ollie's (OLLI) Expands Supply With New Distribution Hub
by Zacks Equity Research
Ollie's (OLLI) expansion of its distribution center in Princeton underscores the company's commitment to delivering exceptional value to customers.
5 Low-Leverage Stocks to Buy on an Optimistic Fed Minutes Report
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not burdened with debt. You can buy low-leverage stocks like VITL, PHM, HG, GBX and KTOS.
Colgate (CL) Benefits From Innovation & Pricing Actions
by Zacks Equity Research
Colgate's (CL) margins benefit from robust pricing and funding-the-growth and other productivity initiatives.